Chemours posts investor presentation with Q2 results
Chemours posted an investor presentation highlighting Q2 2026 results, including $1.59 billion net sales and $247 million adjusted EBITDA.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.